Details of the Drug

General Information of Drug (ID: DMI42MN)

• Drug Name: Carbon dioxide intranasal

Indication

Disease Entry	ICD 11	Status	REF
Trigeminal neuralgia	8B82.0	Phase 2	[1]

• Cross-matching ID: TTD ID: D0G0GP

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)